Meril BioMime™ Morph Sirolimus Eluting Coronary Stent System - HSA Registration DE0505773
Access comprehensive regulatory information for Meril BioMime™ Morph Sirolimus Eluting Coronary Stent System in the Singapore medical device market through Pure Global AI's free database. This CLASS COM medical device is registered under HSA registration number DE0505773 and owned by Meril Life Sciences Pvt. Ltd.. The device was registered on May 12, 2021.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Biomime™ Morph Sirolimus Eluting Coronary Stent System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to de novo & in-stent restenotic lesions (lengths ≤ 56 mm) in native coronary arteries with a reference vessel diameter of 2.25 mm to 3.5 mm in patients eligible for Percutaneous Transluminal Coronary Angioplasty (PTCA) and Stenting procedures.